Bipolar Research Today is a free monthly online journal that collates and summarizes the latest research about Bipolar, including details on bipolar disorder, symptoms, treatment, depression, medication.

Volume 4 (2007), Issue 3 (March)

1. Haplotype association study between DRD1 gene and bipolar type I affective disorder in two samples from Canada and Sardinia.
   Am J Med Genet B Neuropsychiatr Genet, 144(2): 237-41. [Abstract] [Full-text]
2. Towards understanding the schizophrenia code: an expanded convergent functional genomics approach.
   Am J Med Genet B Neuropsychiatr Genet, 144(2): 129-58. [Abstract] [Full-text]
3. Impulsivity and bipolar disorder.
   Eur Neuropsychopharmacol, 17(5): 313-20. [Abstract] [Full-text]
4. What predicts poor mother-infant interaction in schizophrenia?
   Psychol Med, 37(4): 537-46. [Abstract] [Full-text]
5. Selective maximization of (31)P MR spectroscopic signals of in vivo human brain metabolites at 3T.
   J Magn Reson Imaging, 25(3): 628-34. [Abstract] [Full-text]
6. Epigenetic mechanisms expressed in basal ganglia GABAergic neurons differentiate schizophrenia from bipolar disorder.
   Schizophr Res, 91(1): 51-61. [Abstract] [Full-text]
7. Human reward system activation is modulated by a single dose of olanzapine in healthy subjects in an event-related, double-blind, placebo-controlled fMRI study.
   Psychopharmacology (Berl), 191(3): 823-33. [Abstract] [Full-text]
8. Delusional ideation and manic symptoms in potential future emigrants in Uganda.
   Psychol Med, 37(4): 505-12. [Abstract] [Full-text]
9. Aggressive behaviour at first contact with services: findings from the AESOP First Episode Psychosis Study.
   Psychol Med, 37(4): 547-57. [Abstract] [Full-text]
10. Initial symptoms of manic relapse in manic or mixed-manic bipolar disorder: post hoc analysis of patients treated with olanzapine or lithium.
    J Psychiatr Res, 41(7): 616-21. [Abstract] [Full-text]
11. Rate and predictors of treatment prescription for hepatitis C.
    Gut, 56(3): 385-9. [Abstract] [Full-text]
12. Regional cerebral glucose metabolic abnormalities in bipolar II depression.
    Biol Psychiatry, 61(6): 765-75. [Abstract] [Full-text]
13. Voxel-based study of structural changes in first-episode patients with bipolar disorder.
    Biol Psychiatry, 61(6): 776-81. [Abstract] [Full-text]
14. Direct determination of valproic acid in biological fluids by capillary electrophoresis with contactless conductivity detection.
    J Chromatogr B Analyt Technol Biomed Life Sci, 847(2): 205-209. [Abstract] [Full-text]
15. 5HTTLPR polymorphism and enlargement of the pulvinar: unlocking the backdoor to the limbic system.
    Biol Psychiatry, 61(6): 813-8. [Abstract] [Full-text]
16. Reduced amygdala volumes in first-episode bipolar disorder and correlation with cerebral white matter.
    Biol Psychiatry, 61(6): 743-9. [Abstract] [Full-text]
17. Reduction in occipital cortex gamma-aminobutyric acid concentrations in medication-free recovered unipolar depressed and bipolar subjects.
    Biol Psychiatry, 61(6): 806-12. [Abstract] [Full-text]
18. Attention bias to threat faces in children with bipolar disorder and comorbid lifetime anxiety disorders.
    Biol Psychiatry, 61(6): 819-21. [Abstract] [Full-text]
19. Pharmacological treatment of bipolar disorder among children and adolescents.
    Expert Rev Neurother, 7(3): 259-70. [Abstract] [Full-text]
20. No association between the PREP gene and lithium responsive bipolar disorder.
    BMC Psychiatry, 7: 9. [Abstract] [Full-text]
21. Topiramate in adolescents with juvenile bipolar disorder presenting weight gain due to atypical antipsychotics or mood stabilizers: an open clinical trial.
    J Child Adolesc Psychopharmacol, 17(1): 129-34. [Abstract] [Full-text]
22. Manic symptoms and behavioral dysregulation in youth with velocardiofacial syndrome (22q11.2 deletion syndrome).
    J Child Adolesc Psychopharmacol, 17(1): 105-14. [Abstract] [Full-text]
23. Serum neurotrophin-3 is increased during manic and depressive episodes in bipolar disorder.
    Neurosci Lett, 415(1): 87-9. [Abstract] [Full-text]
24. GABA(A) receptor alpha5 subunit as a candidate gene for autism and bipolar disorder: A proposed endophenotype with parent-of-origin and gain-of-function features,with or without oculocutaneous albinism.
    Autism, 11(2): 135-47. [Abstract] [Full-text]
25. Use of treatment guidelines in clinical decision making in bipolar disorder: a pilot survey of clinicians.
    Curr Med Res Opin, 23(3): 467-75. [Abstract] [Full-text]
26. Lack of lithium-like behavioral and molecular effects in IMPA2 knockout mice.
    Neuropsychopharmacology, 32(4): 881-91. [Abstract] [Full-text]
27. The anticonvulsants lamotrigine, riluzole, and valproate differentially regulate AMPA receptor membrane localization: relationship to clinical effects in mood disorders.
    Neuropsychopharmacology, 32(4): 793-802. [Abstract] [Full-text]
28. Sequence and functional analyses of mtDNA in a maternally inherited family with bipolar disorder and depression.
    Mutat Res, 617(1): 119-24. [Abstract] [Full-text]
29. Long-lasting effects of high frequency repetitive transcranial magnetic stimulation in major depressed patients.
    Psychiatry Res, 150(2): 181-6. [Abstract] [Full-text]
30. Combined biological tests for suicide prediction.
    Psychiatry Res, 150(2): 187-91. [Abstract] [Full-text]
31. Hypothalamic-pituitary-end organ function in women with bipolar depression.
    Psychoneuroendocrinology, 32(3): 279-86. [Abstract] [Full-text]
32. Bipolar disorder--focus on bipolar II disorder and mixed depression.
    Lancet, 369(9565): 935-45. [Abstract] [Full-text]
33. Treatments for patients with dual diagnosis: a review.
    Alcohol Clin Exp Res, 31(4): 513-36. [Abstract] [Full-text]
34. Oxcarbazepine in bipolar disorder: a critical review of the literature.
    Expert Opin Pharmacother, 8(5): 649-56. [Abstract] [Full-text]
35. Treating common psychiatric disorders associated with attention-deficit/hyperactivity disorder.
    Expert Opin Pharmacother, 8(5): 555-62. [Abstract] [Full-text]
36. Anticonvulsants in sports: Ethical considerations.
    Epilepsy Behav, 10(2): 268-71. [Abstract] [Full-text]
37. Reduced concentrations of N-acetylaspartate (NAA) and the NAA-creatine ratio in the basal ganglia in bipolar disorder: a study using 3-Tesla proton magnetic resonance spectroscopy.
    Psychiatry Res, 154(3): 259-65. [Abstract] [Full-text]
38. Gender dimorphism in the DAT1 -67 T-allele homozygosity and predisposition to bipolar disorder.
    Brain Res, 1144: 142-5. [Abstract] [Full-text]
39. Safety and tolerability of quetiapine in the treatment of acute mania in bipolar disorder.
    J Affect Disord. [Abstract] [Full-text]
40. Rates of remission/euthymia with quetiapine monotherapy compared with placebo in patients with acute mania.
    J Affect Disord. [Abstract] [Full-text]
41. G protein-coupled receptors in major psychiatric disorders.
    Biochim Biophys Acta, 1768(4): 976-93. [Abstract] [Full-text]
42. Dense SNP association study for bipolar I disorder on chromosome 18p11 suggests two loci with excess paternal transmission.
    Mol Psychiatry, 12(4): 367-75. [Abstract] [Full-text]
43. Quetiapine in the treatment of acute bipolar mania: Efficacy across a broad range of symptoms.
    J Affect Disord. [Abstract] [Full-text]
44. Effect of second-generation antidepressants on mania- and depression-related visits in adults with bipolar disorder: a retrospective study.
    Value Health, 10(2): 128-36. [Abstract] [Full-text]
45. Attentional bias and general orienting processes in bipolar disorder.
    J Behav Ther Exp Psychiatry, 38(2): 168-83. [Abstract] [Full-text]
46. Quetiapine dosage in bipolar disorder episodes and mixed states.
    Prog Neuropsychopharmacol Biol Psychiatry, 31(3): 727-30. [Abstract] [Full-text]
47. Changes in nitric oxide level and superoxide dismutase activity during antimanic treatment.
    Prog Neuropsychopharmacol Biol Psychiatry, 31(3): 697-702. [Abstract] [Full-text]

© 2004-2013 Bipolar Research Today. All Rights Reserved.